These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9392815)

  • 1. Graphical representation of complex data--diurnal patterns of initiations of atrial fibrillation episodes.
    Hnatkova K; Murgatroyd FD; Guo X; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1997 Nov; 20(11):2848-52. PubMed ID: 9392815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of changes in the ventricular rhythm during paroxysmal atrial fibrillation.
    Gallagher MM; Hnatkova K; Murgatroyd FD; Waktare JE; Guo X; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2450-4. PubMed ID: 9825365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and gender influences on rate and duration of paroxysmal atrial fibrillation.
    Hnatkova K; Waktare JE; Murgatroyd FD; Guo X; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2455-8. PubMed ID: 9825366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens.
    Farshi R; Kistner D; Sarma JS; Longmate JA; Singh BN
    J Am Coll Cardiol; 1999 Feb; 33(2):304-10. PubMed ID: 9973007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of fast heart rate episodes during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Alferness CA; Camm AJ; Malik M
    Heart; 1998 May; 79(5):497-501. PubMed ID: 9659199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of digoxin on the ventricular rate variability during paroxysmal atrial fibrillation.
    Hnatkova K; Murgatroyd FD; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1996 Nov; 19(11 Pt 2):1968-71. PubMed ID: 8945079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT/RR relation during atrial fibrillation based on a single beat analysis in 24-h Holter ECG: the role of the second and further preceding RR intervals in QT modification.
    Fujiki A; Yoshioka R; Sakabe M; Kusuzaki S
    J Cardiol; 2011 May; 57(3):269-74. PubMed ID: 21382691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mid- and long-term similarity of ventricular response to paroxysmal atrial fibrillation: digoxin versus placebo.
    Hnatkova K; Murgatroyd FD; Poloniecki J; Waktare JE; Alferness CA; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Sep; 21(9):1735-40. PubMed ID: 9744436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian variation in atrial fibrillation in patients with frequent paroxysms.
    Sopher SM; Hnatkova K; Waktare JE; Murgatroyd FD; Camm AJ; Malik M
    Pacing Clin Electrophysiol; 1998 Nov; 21(11 Pt 2):2445-9. PubMed ID: 9825364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autonomic nervous system and paroxysmal atrial fibrillation: a study based on the analysis of RR interval changes before, during and after paroxysmal atrial fibrillation.
    Lombardi F; Tarricone D; Tundo F; Colombo F; Belletti S; Fiorentini C
    Eur Heart J; 2004 Jul; 25(14):1242-8. PubMed ID: 15246643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian distribution of paroxysmal atrial fibrillation in patients with and without structural heart disease in untreated state.
    Deguchi Y; Amino M; Adachi K; Matsuzaki A; Iwata O; Yoshioka K; Watanabe E; Tanabe T
    Ann Noninvasive Electrocardiol; 2009 Jul; 14(3):280-9. PubMed ID: 19614641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian variation of paroxysmal atrial fibrillation.
    Yamashita T; Murakawa Y; Sezaki K; Inoue M; Hayami N; Shuzui Y; Omata M
    Circulation; 1997 Sep; 96(5):1537-41. PubMed ID: 9315544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods.
    Khand AU; Rankin AC; Cleland JG; Gemmell I; Clark E; Macfarlane PW
    Europace; 2006 Nov; 8(11):927-34. PubMed ID: 17043068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onset mechanism of paroxysmal atrial fibrillation detected by ambulatory Holter monitoring.
    Vincenti A; Brambilla R; Fumagalli MG; Merola R; Pedretti S
    Europace; 2006 Mar; 8(3):204-10. PubMed ID: 16627441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the cardiac rhythm preceding episodes of paroxysmal atrial fibrillation.
    Hnatkova K; Waktare JE; Murgatroyd FD; Guo X; Baiyan X; Camm AJ; Malik M
    Am Heart J; 1998 Jun; 135(6 Pt 1):1010-9. PubMed ID: 9630105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-blind placebo-controlled trial of digoxin in symptomatic paroxysmal atrial fibrillation.
    Murgatroyd FD; Gibson SM; Baiyan X; O'Nunain S; Poloniecki JD; Ward DE; Malik M; Camm AJ
    Circulation; 1999 Jun; 99(21):2765-70. PubMed ID: 10351970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of heart rate variability five minutes before the onset of paroxysmal atrial fibrillation.
    Fioranelli M; Piccoli M; Mileto GM; Sgreccia F; Azzolini P; Risa MP; Francardelli RL; Venturini E; Puglisi A
    Pacing Clin Electrophysiol; 1999 May; 22(5):743-9. PubMed ID: 10353133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Power spectral analysis of heart period variability of preceding sinus rhythm before initiation of paroxysmal atrial fibrillation.
    Herweg B; Dalal P; Nagy B; Schweitzer P
    Am J Cardiol; 1998 Oct; 82(7):869-74. PubMed ID: 9781969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An open label, randomised, crossover study comparing sotalol and atenolol in the treatment of symptomatic paroxysmal atrial fibrillation.
    Steeds RP; Birchall AS; Smith M; Channer KS
    Heart; 1999 Aug; 82(2):170-5. PubMed ID: 10409530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the efficacies of disopyramide, cibenzoline and aprindine for the termination of paroxysmal and persistent atrial fibrillation in elderly and non-elderly patients].
    Komatsu T; Nakamura S; Suzuki O; Yomogida K; Horiuchi D; Abe N; Kameda K; Owada S; Tomita H; Oikawa K; Okumura K
    J Cardiol; 2003 Apr; 41(4):191-8. PubMed ID: 12728540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.